Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-08-31 Purchase |
2023-09-08 5:47 pm |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER |
10,292 | $0.275 | $2,830 | 30,876 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-07 Option Award |
2025-02-11 5:00 pm |
N/A 2035-02-07 |
NRX Pharmaceuticals Inc. | NRXP | ABRAMS MICHAEL S Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
2023-08-31 Option Award |
2023-09-08 5:47 pm |
N/A 2028-08-31 |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER |
20,584 | $0 | 30,876 (Direct) |
View |
2022-11-10 Option Award |
2022-11-10 9:49 pm |
N/A 2032-11-10 |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER |
900,000 | $0 | 900,000 (Direct) |
View |
2022-07-06 Option Award |
2022-07-08 4:57 pm |
N/A N/A |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER |
868,998 | $0 | 868,998 (Direct) |
View |
2021-09-27 Option Award |
2021-10-01 08:17 am |
N/A 2031-09-26 |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S Chief Financial Officer |
350,000 | $0 | 350,000 (Direct) |
View |
Ownership |
2021-05-10 08:02 am |
N/A 2031-05-02 |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CFO and Treasurer |
0 | $0 | 500,000 (Direct) |
View |